VITASPRING BIOMEDICAL CO. LTD. (VSBC) stock: key figures, P/E, revenue and dividend
Industrials · United States · ISIN US92851B1026
VITASPRING BIOMEDICAL CO. LTD. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Gross profit | 0.00 USD | 0.00 USD |
| Operating income | -679,914.00 USD | -385,411.00 USD |
| EBIT | -679,914.00 USD | -385,411.00 USD |
| Net income | -774,922.00 USD | -415,368.00 USD |
| Diluted EPS – continuing operations | 0.00 USD | 0.00 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About VITASPRING BIOMEDICAL CO. LTD.
VitaSpring Biomedical Co. Ltd., a development-stage biomedical company, engages in the research, development, and commercialization of wellness and healthy lifestyle products. It focuses on the development of cell-based medical technologies for use in regenerative medicine, preventive health care, beauty, and anti-aging applications. The company is also involved in the development of cell medical treatment. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is based in Riverside, California.
More stocks
- Indaptus Therapeutics, Inc. (INDP)
- MacKenzie Realty Capital, Inc. (MKZR)
- Quest Water Global, Inc. (QWTR)
- AIRWA INC. (YYAI)
- Medicus Pharma Ltd. (MDCX)
- Wenyuan Group Corp. (WYGC)
- NOCERA, INC. (NCRA)
- Vemanti Group, Inc. (VMNT)
- CHASE PACKAGING CORP (WHLT)
- Fly-E Group, Inc. (FLYE)
- PharmaCyte Biotech, Inc. (PMCB)
- DNA X, Inc. (SONM)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.